Join us for a deep dive into hepatocellular carcinoma (HCC) therapy with leaders in the field: Dr. Parissa Tabrizian and Dr. Ju Dong Yang.

In this episode, we break down the modern management of HCC across disease stages, from surgical resection and locoregional therapies to systemic and immunotherapy options. Our guests walk us through real-world clinical decision-making and the nuances of multidisciplinary care in an increasingly complex treatment landscape.

We also feature a special segment at the end with Dr. Allie Cao who is the trainee lead for the HCC Special Interest Group (SIG).

Hosts:

Vlad Fomin

Dilara Hatipoglu

Adam Winters

Alex Vogel

Edited By:

Taylor Gouterman